UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000008366
Receipt number R000009835
Scientific Title A phase II study of gefitinib with concurrent thoracic radiotherapy in patients with unresectable, stage III Non-Small Cell Lung Cancer harboring EGFR mutations.
Date of disclosure of the study information 2012/07/06
Last modified on 2023/05/17 11:26:15

No. Disposal Last modified on Item of update
1 Insert 2012/07/06 09:32:28
2 Update 2012/09/10 10:41:09 Recruitment status
3 Update 2013/01/07 09:06:37 Anticipated trial start date
4 Update 2014/08/21 09:00:06 Email
Email1
5 Update 2014/09/10 09:10:26 Name of person sending information
Name of person sending information
6 Update 2016/07/06 09:04:29 Name of primary person or sponsor
Organization
7 Update 2016/08/12 11:51:30 Target sample size
8 Update 2016/08/12 11:57:35 Organization
Organization
Organization
Category of Funding Organization
9 Update 2017/11/08 17:33:06 Recruitment status
10 Update 2019/07/12 09:17:01 Number of participants that the trial has enrolled
11 Update 2019/07/12 09:19:13 Date of IRB
Anticipated trial start date
Last follow-up date
12 Update 2020/12/18 16:10:39 Recruitment status
13 Update 2023/05/17 11:23:05 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
14 Update 2023/05/17 11:26:15 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures